Lipocine Inc. — Director's Dealing 2016

Jan 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2016-01-05

Reporting Person: Mattila Jyrki (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-05	Stock Option (Right to Buy)	$12.92	A	40000	Acquired	2026-01-05	Common Stock (40000)	Direct

Footnotes

F1: Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 5, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years